Acurx Pharmaceuticals Chairman Robert DeLuccia's 2023 pay jumps 56% to $1.1M
Acurx Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: April 29, 2024
Acurx Pharmaceuticals reported fiscal year 2023 executive compensation information on April 29, 2024.
In 2023, three executives at Acurx Pharmaceuticals received on average a compensation package of $918K, a 61% increase compared to previous year.
Average pay of disclosed executives at Acurx Pharmaceuticals
Robert J. DeLuccia, Chairman, received $1.1M in total, which increased by 56% compared to 2022. 46% of DeLuccia's compensation, or $485K, was in salary. DeLuccia also received $194K in bonus, $355K of change in pension value and nonqualified deferred compensation earnings, as well as $23K in other compensation.
David P. Luci, Chief Executive Officer, received a compensation package of $1M, which increased by 56% compared to previous year. 46% of the compensation package, or $475K, was in salary.
Robert G. Shawah, Chief Financial Officer, earned $675K in 2023, a 80% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2024.